Raymond James Trust Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Raymond James Financial
RJF
|
+$14.2M |
| 2 |
Fulgent Genetics
FLGT
|
+$14.1M |
| 3 |
Coca-Cola
KO
|
+$10.6M |
| 4 |
Hershey
HSY
|
+$4.35M |
| 5 |
Aflac
AFL
|
+$3.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.94M |
| 2 |
Apple
AAPL
|
+$2.68M |
| 3 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$1.34M |
| 4 |
Vanguard US Momentum Factor ETF
VFMO
|
+$1.27M |
| 5 |
Xcel Energy
XEL
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.25% |
| 2 | Healthcare | 12.65% |
| 3 | Financials | 9.87% |
| 4 | Consumer Staples | 8.33% |
| 5 | Consumer Discretionary | 6.65% |
Similar funds
Raymond James Trust's Q3 2020 Portfolio in Review
As of Q3 2020, Raymond James Trust held 1,016 positions worth $2.32B, up 12% from $2.07B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Raymond James Trust deployed $91.3M of net new capital in Q3 2020, opening 86 new positions and adding to 453 existing holdings. Its largest new stake was Invesco S&P SmallCap Low Volatility ETF: 28,363 shares worth $942K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $2.94M trimmed.
- Raymond James Trust's largest Q3 2020 buy was Invesco S&P SmallCap Low Volatility ETF: 28,363 shares worth $942K.
- Raymond James Trust added most to Raymond James Financial in Q3 2020, an estimated $14.2M increase.
- Raymond James Trust's biggest Q3 2020 reduction was Microsoft, cutting an estimated $2.94M.
- Raymond James Trust fully exited Invesco S&P 500 Pure Value ETF in Q3 2020, selling an estimated $1.34M.
- Raymond James Trust's ten largest holdings make up 21% of its $2.32B portfolio in Q3 2020.
- Raymond James Trust opened 86 new positions and closed 38 in Q3 2020.
- Raymond James Trust's portfolio value rose 12% quarter-over-quarter to $2.32B.
Based on Raymond James Trust's 13F filing for Q3 2020, filed 14 Oct 2020.